Brickell Biotech, Inc.

Brickell Biotech, Inc., a clinical-stage pharmaceutical company, focuses on identifying, developing, and commercializing various prescription therapeutics for the treatment of debilitating skin diseases in the United States. Show More...

  • Website http://www.brickellbio.com
  • Sector Healthcare
  • Industry Biotechnology
  • Last Quote 0.90 USD
  • Last Updated 19-04-2024
  • External Links Yahoo Finance Morningstar Ratios
  •   2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM
    Earnings Per Share USD -35.7 -7.0 -18.9 -25.2 -13.02 -7.07 -6.3 -7.07 -5.18 -4.5 -15.03
    Dividends USD
    Payout Ratio % *
    Shares Mil 1.0 1.0 1.0 1.0 1.0 1.0 1.0 2.0 3.0 3.0 5.0
    Book Value Per Share * USD 62.89 64.76 72.4 50.73 43.13 36.28 30.32 12.12 16.71 2.15 0.61
    Free Cash Flow Per Share * USD -33.77 -4.79 -15.17 -25.28 -10.32 -6.08 -6.34 -5.47 -4.59 -13.5
    Return on Assets % -43.32 -10.28 -27.71 -38.36 -26.53 -17.12 -17.56 -19.52 -24.47 -38.6 -79.5
    Financial Leverage (Average) 1.13 1.14 1.08 1.08 1.12 1.1 1.16 1.27 1.07 2.4 2.21
    Return on Equity % -50.92 -11.68 -30.65 -41.51 -29.1 -18.99 -19.82 -23.84 -28.94 -48.29 -94.93
    Return on Invested Capital % -50.92 -11.68 -30.65 -41.51 -29.1 -18.99 -19.82 -23.84 -28.94 -40.63 -86.95
    Interest Coverage -10.39 -11.5
    Current Ratio 8.87 8.29 14.88 15.9 9.87 10.69 6.7 4.51 13.74 1.71 1.82
    Quick Ratio 8.41 7.83 14.35 15.05 9.26 9.91 6.23 3.88 13.74 1.12 1.01
    Debt/Equity 0.010